Prashant Kumar Singh 1,2 , Amit Yadav 3 , Lucky Singh 4 , Sumit Mazumdar 5 , Dhirendra N Sinha 6 , Kurt Straif 7,8 , Shalini Singh 2,9 . Show Affiliations »
Abstract
OBJECTIVE: Areca nut is one of the most widely consumed substances globally, after nicotine, ethanol and caffeine and classified as carcinogenic to humans. This study examines the disparity and determinants of areca nut consumption with and without tobacco in India. DESIGN: Nationally representative cross-sectional study. PARTICIPANTS: We used the nationally representative Global Adult Tobacco Survey 2016-2017. The analytical sample size was 74 037 individual's aged 15 years and above with a response rate of 92.9%. MEASURES: Current consumption of areca nut without tobacco and with tobacco. METHOD: We examined determinants of areca nut consumption (without tobacco and with tobacco) using multinomial logistic regression, accounting for the survey design. RESULTS: About 23.9% (95% CI 23.1 to 24.8) of the adult population consume areca nut, that is, approximately 223.79 million people in India; majority of users (14.2%-95% CI 13.5 to 14.9) consumed areca nut with tobacco. When compared with women, men were more likely to consume areca nut (with tobacco relative risk (RR)=2.02; 95% CI 1.85 to 2.21 and without tobacco RR=1.13; 95% CI 1.07 to 1.20). Age, marital status, education, occupation, caste, religion and region were significantly associated with areca nut consumption. However, the direction and magnitude of association differ with respect to the areca nut consumption with and without tobacco. CONCLUSION: The ongoing tobacco control efforts would not address the majority of areca nut users until greater attention to areca nut consumption with and without tobacco is reflected in health policies in India. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
OBJECTIVE: Areca nut is one of the most widely consumed substances globally, after nicotine , ethanol and caffeine and classified as carcinogenic to humans . This study examines the disparity and determinants of areca nut consumption with and without tobacco in India. DESIGN: Nationally representative cross-sectional study. PARTICIPANTS : We used the nationally representative Global Adult Tobacco Survey 2016-2017. The analytical sample size was 74 037 individual's aged 15 years and above with a response rate of 92.9%. MEASURES: Current consumption of areca nut without tobacco and with tobacco . METHOD: We examined determinants of areca nut consumption (without tobacco and with tobacco ) using multinomial logistic regression, accounting for the survey design. RESULTS: About 23.9% (95% CI 23.1 to 24.8) of the adult population consume areca nut , that is, approximately 223.79 million people in India; majority of users (14.2%-95% CI 13.5 to 14.9) consumed areca nut with tobacco . When compared with women , men were more likely to consume areca nut (with tobacco relative risk (RR)=2.02; 95% CI 1.85 to 2.21 and without tobacco RR=1.13; 95% CI 1.07 to 1.20). Age, marital status, education, occupation, caste, religion and region were significantly associated with areca nut consumption. However, the direction and magnitude of association differ with respect to the areca nut consumption with and without tobacco . CONCLUSION: The ongoing tobacco control efforts would not address the majority of areca nut users until greater attention to areca nut consumption with and without tobacco is reflected in health policies in India. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Entities: Chemical
Disease
Gene
Species
Keywords:
cancer pain; health policy; public health
Year: 2021
PMID: 34130957 DOI: 10.1136/bmjopen-2020-043987
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692